Metoclopramide: No Link Seen With Birth Defects, Stillbirth Metoclopramide: No Link Seen With Birth Defects, Stillbirth
A study of more than 40,000 women who used metoclopramide during pregnancy found no significant link between use of the drug and risks for congenital malformations or other adverse outcomes. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 15, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Nausea Drug Safe During Pregnancy (CME/CE)
(MedPage Today) -- There was no association between exposure to metoclopramide (Reglan) during pregnancy and an increased risk of birth defects, spontaneous abortion, or stillbirth, according to results of a large, register-based study. (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - October 15, 2013 Category: OBGYN Source Type: news
Medication taken for nausea during pregnancy not associated with increased risk of major malformations, stillbirth
In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, spontaneous abortion, and stillbirth, according to a study in the October 16 issue of JAMA. More than 50 percent of pregnant women experience nausea and vomiting, typically early in their pregnancy. The care of most women is managed conservatively, but 10 percent to 15 percent of those with nausea and vomiting will eventually receive drug treatment... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 15, 2013 Category: Consumer Health News Tags: Pregnancy / Obstetrics Source Type: news
Metoclopramide Injection And Ondansetron Injection by Hospira: Recall - Glass Strand Particulates Caused By Glass Supplier
Administration of an injectable with the presence of foreign particulates may result in local inflammation,
thrombophlebitis, and/or low-level allergic response. (Source: FDA MedWatch)
Source: FDA MedWatch - October 2, 2013 Category: American Health Source Type: news
Hospira issues a voluntary nationwide recall of one lot of metoclopramide injection, usp, and two lots of ondansetron injection, usp, due to glass (glass strands) particulates caused by glass supplier defect
Hospira, Inc. (NYSE: HSP), announced today it initiated a voluntary nationwide recall of one lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL), NDC 0409-3414-01, Lot 28-104-DK and two lots of Ondansetron Injection, USP, 4 mg/2 mL, (2 mg/mL), NDC 0409-4755-03, Lots 29-484-DK and 29-510-DK. This action is due to a confirmed vial defect where glass particulate matter (glass strands) were identified as being affixed to the inside of the vial walls. There is potential for the glass particulates to dislodge into the solution. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 2, 2013 Category: Food Science Source Type: news
The Metoclopramide Black Box Warning for Tardive DyskinesiaThe Metoclopramide Black Box Warning for Tardive Dyskinesia
This study investigated the effect on one large practice. The American Journal of Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 15, 2013 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Clinical Notes: Nausea Drug Risky for Kids
(MedPage Today) -- Metoclopramide should be avoided whenever possible in children because of the drug's neurological toxicity, the European Medicines Agency said. Also this week: A new TB test won FDA approval. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 28, 2013 Category: American Health Source Type: news
Europe Recommends Restrictions for MetoclopramideEurope Recommends Restrictions for Metoclopramide
The Committee on Medicinal Products for Human Use has recommended restrictions on metoclopramide to minimize neurologic adverse effects. News Alerts (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 26, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
Metoclopramide, Ondansetron Cut Nausea in Cesarean DeliveryMetoclopramide, Ondansetron Cut Nausea in Cesarean Delivery
A new study has suggested that adding metoclopramide and ondansetron drugs to a phenylephrine infusion during a cesarean delivery reduces vomiting and nausea. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 7, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
